AR065085A1 - Metodo para tratamiento prolongado del acne vulgaris - Google Patents

Metodo para tratamiento prolongado del acne vulgaris

Info

Publication number
AR065085A1
AR065085A1 ARP080100366A ARP080100366A AR065085A1 AR 065085 A1 AR065085 A1 AR 065085A1 AR P080100366 A ARP080100366 A AR P080100366A AR P080100366 A ARP080100366 A AR P080100366A AR 065085 A1 AR065085 A1 AR 065085A1
Authority
AR
Argentina
Prior art keywords
acne vulgaris
prolonged treatment
term treatment
long
treatment
Prior art date
Application number
ARP080100366A
Other languages
English (en)
Inventor
Michael Graeber
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39473958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR065085(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR065085A1 publication Critical patent/AR065085A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Abstract

Uso de una composicion que comprende adapaleno y peroxido de benzoilo, en la preparacion de un medicamento topico para administrar a un paciente que lo necesita, a fin de proveer un tratamiento a largo plazo del acné vulgar, y provee un metodo de tratamiento a largo plazo del acné vulgar.
ARP080100366A 2007-01-30 2008-01-30 Metodo para tratamiento prolongado del acne vulgaris AR065085A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89811307P 2007-01-30 2007-01-30

Publications (1)

Publication Number Publication Date
AR065085A1 true AR065085A1 (es) 2009-05-13

Family

ID=39473958

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080100366A AR065085A1 (es) 2007-01-30 2008-01-30 Metodo para tratamiento prolongado del acne vulgaris

Country Status (16)

Country Link
US (3) US8809305B2 (es)
EP (1) EP2114392B1 (es)
JP (1) JP2011510907A (es)
AR (1) AR065085A1 (es)
AU (1) AU2008209730B2 (es)
CA (1) CA2677167A1 (es)
CY (1) CY1116672T1 (es)
DK (1) DK2114392T3 (es)
ES (1) ES2546029T3 (es)
HR (1) HRP20150940T1 (es)
HU (1) HUE025484T2 (es)
PL (1) PL2114392T3 (es)
PT (1) PT2114392E (es)
RU (1) RU2481832C2 (es)
SI (1) SI2114392T1 (es)
WO (1) WO2008092911A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
EP2854791A1 (en) * 2012-05-25 2015-04-08 Galderma Research & Development Treatment of preadolescent moderate acne vulgaris
WO2015150332A1 (en) * 2014-04-01 2015-10-08 Galderma Research & Development Combination of adapalene and benzoyl peroxide for treating acne scars
CN108024980A (zh) * 2015-08-20 2018-05-11 索尔-格尔科技有限公司 包含过氧化苯甲酰和阿达帕林的用于局部施用的组合物
US10722488B2 (en) 2016-06-07 2020-07-28 Rodan & Fields, Llc Hest G-18-0 and benzoyl peroxide compositions and methods for using the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343237B1 (en) * 1987-12-05 1992-06-17 Renishaw plc Apparatus for changing a sensing device
US5327657A (en) * 1991-07-11 1994-07-12 Renishaw Metrology Ltd. Touch probe
US5393288A (en) * 1991-11-26 1995-02-28 Mutoh Industries Ltd. Three-dimensional processing machine and a method of processing a workpiece
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5646049A (en) * 1992-03-27 1997-07-08 Abbott Laboratories Scheduling operation of an automated analytical system
US6559189B2 (en) * 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
GB0115788D0 (en) * 2001-06-28 2001-08-22 Renishaw Plc Tool identification
US6572312B2 (en) * 2001-07-20 2003-06-03 Cottrell, Inc. Power screw load retention apparatus and system
GB0129471D0 (en) * 2001-12-10 2002-01-30 Renishaw Plc Rack and change system
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US20060128808A1 (en) * 2004-10-20 2006-06-15 Galderma Research & Development, S.N.C. Method of using adapalene in acne maintenance therapy
ES2551011T3 (es) * 2005-01-26 2015-11-13 Galderma Research & Development Adapaleno para el tratamiento a largo plazo del acné vulgar
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
CA2656451C (en) * 2006-07-13 2015-01-27 Galderma Research & Development Composition comprising a retinoid and benzoyl peroxide

Also Published As

Publication number Publication date
PL2114392T3 (pl) 2015-11-30
ES2546029T3 (es) 2015-09-17
HRP20150940T1 (hr) 2015-11-20
EP2114392A1 (en) 2009-11-11
US8809305B2 (en) 2014-08-19
RU2009132502A (ru) 2011-03-10
SI2114392T1 (sl) 2016-01-29
CY1116672T1 (el) 2017-03-15
JP2011510907A (ja) 2011-04-07
CA2677167A1 (en) 2008-08-07
WO2008092911A1 (en) 2008-08-07
EP2114392B1 (en) 2015-06-10
DK2114392T3 (en) 2015-09-07
HUE025484T2 (en) 2016-02-29
US20140336257A1 (en) 2014-11-13
AU2008209730A1 (en) 2008-08-07
US20100029762A1 (en) 2010-02-04
AU2008209730B2 (en) 2013-08-15
US20170216235A1 (en) 2017-08-03
RU2481832C2 (ru) 2013-05-20
PT2114392E (pt) 2015-10-13

Similar Documents

Publication Publication Date Title
AR061989A1 (es) Combinacion de peroxido de adapaleno y benzoilo para el tratamiento de lesiones de acne
CL2008000606A1 (es) Composicion analgesica en forma de dosificacion parenteral unitaria o en una forma de dosificacion unitaria adecuada para una administracion por la mucosa o la dermis que comprende buprenorfina y naloxona, util para el tratamiento del dolor.
AR084691A1 (es) Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
EP3501546A3 (de) Cystein-wirkstoff konjugate und ihre verwendung
WO2010045415A3 (en) Topical nsaid compositions having sensate component
WO2010070675A3 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
AR067347A1 (es) Combinacion antihelmintica
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
AR065085A1 (es) Metodo para tratamiento prolongado del acne vulgaris
EP1977757A3 (de) Verwendung von Pelargonium in Kombination mit Plantago zur Herstellung eines Medikaments zur Prophylaxe/Behandlung der Mund- oder Rachenentzündung
CL2013001250A1 (es) Composicion intravenosa que contiene ibuprofeno y paracetamol combinados en dosis definidas; y uso en el tratamiento del dolor y/o inflamacion.
WO2010131887A2 (ko) 탈모 방지 또는 육모 촉진을 위한 조성물
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
CL2008000607A1 (es) Composicion analgesica en forma de dosificacion parenteral unitaria o en una forma de dosificacion unitaria adecuada para una administracion por la mucosa o la dermis que comprende buprenorfina y nalmefeno, util para el tratamiento del dolor.
CL2011000388A1 (es) Combinacion farmaceutica que comprende (6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol y un antiinflamatorio no esteroidal; forma de dosificacion; uso en el tratamiento de la osteoartritis y el dolor.
CO6531499A2 (es) Uso de ranolazina para el tratameinto de enfermedades cardiovasculares
CO6541630A2 (es) Combinación teobromina con un descongestivo y su uso para el tratamiento de la tos
CL2008000965A1 (es) Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor.
CL2008000227A1 (es) Composicion farmaceutica que comprende una combinacion de uso oral de tramadol y ketoprofeno; y uso en el tratamiento del dolor.
MY164112A (en) A combination composition comprising ibuprofen and paracetamol

Legal Events

Date Code Title Description
FB Suspension of granting procedure